ImClone Systems

440 Route 22 East
New Jersey
United States

Tel: 908-541-8000

Show jobs for this employer

About ImClone Systems

ImClone Systems is a wholly-owned subsidiary of Eli Lilly and Company and part of Lilly’s oncology business unit. Dedicated to changing the world of cancer care, ImClone is developing its robust pipeline of novel monoclonal antibodies to treat a broad range of tumor types. ImClone is headquartered in New Jersey, where it has one of the world’s largest state-of-the-art biologics manufacturing operations, and it has research laboratories in New York City as well as offices in Europe.

261 articles with ImClone Systems